Prevalence and clinical characteristics of patients with metabolic dysfunction‐associated fatty liver disease with hepatitis C virus infection—a population‐based study-Reference-Cited by-同舟云学术

Prevalence and clinical characteristics of patients with metabolic dysfunction‐associated fatty liver disease with hepatitis C virus infection—a population‐based study

Published:2022-09-27 Issue:11-12 Volume:56 Page:1581-1590
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Attia Dina¹^ORCID,Abdel Alem Shereen²^ORCID,El‐Akel Wafaa²,Abdel‐Razek Wael³^ORCID,Eslam Mohamed⁴⁵,Fouad Yasser⁶^ORCID,Waked Imam⁷^ORCID

Affiliation:

1. Beni‐Suef University Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine Beni Suef Egypt

2. Cairo University Department of Endemic Medicine, Faculty of Medicine Cairo Egypt

3. Ain Shams University (MOH) Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine Cairo Egypt

4. Storr Liver Centre, Westmead Institute for Medical Research Westmead Hospital Westmead New South Wales Australia

5. University of Sydney Sydney New South Wales Australia

6. Minia University Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine Minia Egypt

7. National Liver Institute Department of Hepatology Shebeen el Kom Egypt

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17233

Reference24 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

3. From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?

4. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

5. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD;Hepatology International;2024-08-08

2. Food inequity and insecurity and MASLD: burden, challenges, and interventions;Nature Reviews Gastroenterology & Hepatology;2024-07-29

3. Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis;Journal of Interferon & Cytokine Research;2024-03-01

4. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades;Digestive and Liver Disease;2024-01

5. What the New Definition of MASLD Left Behind: Dual Etiology With Viral Hepatitis;Clinical Gastroenterology and Hepatology;2023-11